Abstract Background Advanced pancreatic cancer has a poor prognosis. and the current standard of care (gemcitabine based chemotherapy) provides a small survival advantage. However the drawback is the accompanying systemic toxicity. which targeted treatments may overcome. https://halohealthcarers.shop/product-category/ball-chairs/